Understanding RAMPs through genetically engineered mouse models

Advances in Experimental Medicine and Biology

Volumn 744, Issue , 2012, Pages 49-60

  Kadmiel, Mahita ^a   Fritz Six, Kimberly L ^a   Caron, Kathleen M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; CALCITONIN RECEPTOR LIKE RECEPTOR; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3;

ARTICLE; GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ENGINEERING; HAPLOINSUFFICIENCY; INTERMETHOD COMPARISON; KNOCKOUT MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR ACTIVITY MODIFYING PROTEIN 1 GENE; RECEPTOR ACTIVITY MODIFYING PROTEIN 2 GENE; RECEPTOR ACTIVITY MODIFYING PROTEIN 3 GENE; TRANSGENIC MOUSE;

ANIMALS; GENETIC ENGINEERING; MICE; MODELS, ANIMAL; RECEPTOR ACTIVITY-MODIFYING PROTEINS;

EID: 84859790113     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-2364-5_5     Document Type: Article

References (26)

1. McLatchie LM, Fraser NJ, Main MJ et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393(6683):333-339. (Pubitemid 28269699)
2. Sexton PM, Morfis M, Tilakaratne N et al. Complexing receptor pharmacology: Modulation of family B G protein-coupled receptor function by RAMPs. Ann NY Acad Sci 2006; 1070:90-104. (Pubitemid 44126627)
3. Bouschet T, Martin S, Henley JM. Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. J Cell Sci 2005; 118(Pt 20):4709-4720. (Pubitemid 41646381)
4. Kunz TH, Mueller-Steiner S, Schwerdtfeger K et al. Interaction of receptor-activity-modifying protein1 with tubulin. Biochim Biophys Acta 2007; 1770(8):1145-1150. (Pubitemid 47002143)
5. Sexton PM, Poyner DR, Simms J et al. Hay DL. Modulating receptor function through RAMPs: Can they represent drug targets in themselves? Drug Discov Today 2009; 14(7-8):413-419.
6. Morfis M, Tilakaratne N, Furness SG et al. Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors. Endocrinology 2008; 149(11):5423-5431.
7. Hay DL, Poyner DR, Sexton PM. GPCR modulation by RAMPs. Pharmacol Ther 2006; 109(1-2):173-197. (Pubitemid 41740820)
8. Kadmiel M, Fritz-Six K, Pacharne S et al. Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice. Mol Endocrinol 2011; 25(7):1244-53.
9. Tsujikawa K, Yayama K, Hayashi T et al. Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci USA 2007; 104(42):16702-16707. (Pubitemid 350211080)
10. Zhang Z, Winborn CS, Marquez de Prado B et al. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 2007; 27(10):2693-2703. (Pubitemid 46393588)
11. Chrissobolis S, Zhang Z, Kinzenbaw DA et al. Receptor activity-modifying protein-1 augments cerebrovascular responses to calcitonin gene-related peptide and inhibits angiotensin II-induced vascular dysfunction. Stroke 2010; 41(10):2329-2334.
12. Sabharwal R, Zhang Z, Lu Y et al. Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension. Hypertension 2010; 55(3):627-635.
13. Ichikawa-Shindo Y, Sakurai T, Kamiyoshi A et al. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J Clin Invest 2008; 118(1):29-39.
14. Fritz-Six KL, Dunworth WP, Li M et al. Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest 2008; 118(1):40-50.
15. Dackor R, Fritz-Six K, Smithies O et al. Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. J Biol Chem 2007; 282(25):18094-18099. (Pubitemid 47100252)
16. Caron KM, Smithies O. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. Proc Natl Acad Sci USA 2001; 98(2):615-619. (Pubitemid 32105091)
17. Dackor RT, Fritz-Six K, Dunworth WP et al. Hydrops fetalis, cardiovascular defects and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene. Mol Cell Biol 2006; 26(7):2511-2518.
18. Oliver G. Lymphatic vasculature development. Nat Rev Immunol 2004; 4(1):35-45. (Pubitemid 38084130)
19. Petrova TV, Makinen T, Makela TP et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 2002; 21(17):4593-4599. (Pubitemid 34984346)
20. Hirakawa S, Hong YK, Harvey N et al. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 2003; 162(2):575-586. (Pubitemid 36267864)
21. Podgrabinska S, Braun P, Velasco P et al. Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci USA 2002; 99(25):16069-16074. (Pubitemid 35462750)
22. Tammela T, Petrova TV, Alitalo K. Molecular lymphangiogenesis: New players. Trends Cell Biol 2005; 15(8):434-441. (Pubitemid 41125775)
23. Kahn ML. Blood is thicker than lymph. J Clin Invest 2008; 118(1):23-26.
24. Li M, Yee D, Magnuson TR, et al. Reduced maternal expression of adrenomedullin disrupts fertility, placentation and fetal growth in mice. J Clin Invest 2006; 116(10):2653-2662. (Pubitemid 44511629)
25. Li M, Wu Y, Caron KM. Haploinsufficiency for Adrenomedullin Reduces Pinopodes and Diminishes Uterine Receptivity in Mice. Biol Reprod 2008.
26. Tam CW, Husmann K, Clark NC et al. Enhanced vascular responses to adrenomedullin in mice overexpressing receptor-activity-modifying protein 2. Circ Res 2006; 98(2):262-270.